| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ENSACLP00000012075 | THAP1 | ENSACLP00000012075 | ENSACLP00000007175 | cGMP-dependent protein kinase. | THAP domain containing 1. | 0.758 |
| ENSACLP00000012075 | pln | ENSACLP00000012075 | ENSACLP00000003970 | cGMP-dependent protein kinase. | Cardiac phospholamban; Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2. Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. | 0.731 |
| ENSACLP00000030247 | THAP1 | ENSACLP00000030247 | ENSACLP00000007175 | Uncharacterized protein. | THAP domain containing 1. | 0.856 |
| ENSACLP00000031541 | THAP1 | ENSACLP00000031541 | ENSACLP00000007175 | Protein kinase, cAMP-dependent, regulatory, type II, alpha, B. | THAP domain containing 1. | 0.834 |
| ENSACLP00000031541 | prkar1a | ENSACLP00000031541 | ENSACLP00000020882 | Protein kinase, cAMP-dependent, regulatory, type II, alpha, B. | Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) b. | 0.887 |
| ENSACLP00000031541 | prkar1b | ENSACLP00000031541 | ENSACLP00000041196 | Protein kinase, cAMP-dependent, regulatory, type II, alpha, B. | Protein kinase, cAMP-dependent, regulatory, type I, beta. | 0.887 |
| ENSACLP00000031541 | prkar2a | ENSACLP00000031541 | ENSACLP00000028805 | Protein kinase, cAMP-dependent, regulatory, type II, alpha, B. | Protein kinase, cAMP-dependent, regulatory, type II, alpha A. | 0.899 |
| ENSACLP00000031541 | prkar2b | ENSACLP00000031541 | ENSACLP00000007011 | Protein kinase, cAMP-dependent, regulatory, type II, alpha, B. | Protein kinase cAMP-dependent type II regulatory subunit beta. | 0.903 |
| ENSACLP00000031946 | THAP1 | ENSACLP00000031946 | ENSACLP00000007175 | Uncharacterized protein. | THAP domain containing 1. | 0.856 |
| THAP1 | ENSACLP00000012075 | ENSACLP00000007175 | ENSACLP00000012075 | THAP domain containing 1. | cGMP-dependent protein kinase. | 0.758 |
| THAP1 | ENSACLP00000030247 | ENSACLP00000007175 | ENSACLP00000030247 | THAP domain containing 1. | Uncharacterized protein. | 0.856 |
| THAP1 | ENSACLP00000031541 | ENSACLP00000007175 | ENSACLP00000031541 | THAP domain containing 1. | Protein kinase, cAMP-dependent, regulatory, type II, alpha, B. | 0.834 |
| THAP1 | ENSACLP00000031946 | ENSACLP00000007175 | ENSACLP00000031946 | THAP domain containing 1. | Uncharacterized protein. | 0.856 |
| THAP1 | pln | ENSACLP00000007175 | ENSACLP00000003970 | THAP domain containing 1. | Cardiac phospholamban; Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2. Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. | 0.815 |
| THAP1 | prkar1a | ENSACLP00000007175 | ENSACLP00000020882 | THAP domain containing 1. | Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) b. | 0.834 |
| THAP1 | prkar1b | ENSACLP00000007175 | ENSACLP00000041196 | THAP domain containing 1. | Protein kinase, cAMP-dependent, regulatory, type I, beta. | 0.834 |
| THAP1 | prkar2a | ENSACLP00000007175 | ENSACLP00000028805 | THAP domain containing 1. | Protein kinase, cAMP-dependent, regulatory, type II, alpha A. | 0.834 |
| THAP1 | prkar2b | ENSACLP00000007175 | ENSACLP00000007011 | THAP domain containing 1. | Protein kinase cAMP-dependent type II regulatory subunit beta. | 0.834 |
| THAP1 | prkg2 | ENSACLP00000007175 | ENSACLP00000003181 | THAP domain containing 1. | cGMP-dependent protein kinase. | 0.758 |
| pln | ENSACLP00000012075 | ENSACLP00000003970 | ENSACLP00000012075 | Cardiac phospholamban; Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2. Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. | cGMP-dependent protein kinase. | 0.731 |